Target intelligence / Profile preview

novel transcript, antisense to ETFA (ENSG00000287503)

Target
ENSG00000287503
Molecular classification
Long non-coding RNA (lncRNA), Antisense transcript, Other
01

Overview

The "novel transcript, antisense to ETFA" (ENSG00000287503) is a long non-coding RNA identified in genome annotations as being transcribed from the DNA strand opposite to the ETFA gene, which encodes the alpha subunit of electron transfer flavoprotein, an enzyme critical for mitochondrial fatty acid and amino acid metabolism[2][3][4]. However, this antisense transcript is not annotated as a protein-coding gene nor as a well-characterized regulatory element. There is insufficient evidence to suggest it functions as a therapeutic target or has experimentally validated biological roles, disease associations, or therapeutic significance. Its naming and gene symbol suggest it is best classified as a non-coding RNA of uncertain significance, not as a classical drug target, receptor, enzyme, transporter, or transcription factor.

Other names
ENSG00000287503Antisense RNA to ETFANon-coding RNA antisense to ETFA
02

Biological functions

UnknownPotential regulatory roles in ETFA expression (hypothetical, not experimentally validated)Other
03

Disease associations

OtherNo demonstrated pathological or disease association

Beyond the preview

Go deeper on novel transcript, antisense to ETFA (ENSG00000287503).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to ETFA (ENSG00000287503).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call